| Nov 8 |
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals
|
| Aug 15 |
Yield10 Bioscience GAAP EPS of -$5.04 misses by $4.01
|
| Aug 14 |
Yield10 Bioscience Announces Second Quarter 2024 Financial Results
|
| Jul 17 |
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
|
| Jun 17 |
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
|
